Patents by Inventor Johannes Albert Foekens

Johannes Albert Foekens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining the estrogen receptor status of breast cancer
    Patent number: 9075061
    Abstract: The present invention relates to a method for determining the estrogen receptor status of patients suffering from breast cancer. The present invention also aims to provide methods and devices for predicting the response of patients diagnosed with breast cancer to specific medicaments. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels and profiles in samples obtained from patients diagnosed with breast cancer.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: July 7, 2015
    Assignee: PamGene B.V.
    Inventors: Robby Ruijtenbeek, Maria Helena Hilhorst, Arzu Umar, Johannes Albert Foekens, Johannes Wilhelmus Maria Martens
  • BIOMARKERS FOR TRIPLE NEGATIVE BREAST CANCER
    Publication number: 20150079078
    Abstract: The present invention relates to biomarkers that are useful in the prognosis of triple negative breast cancer patients. The biomarkers may be used to select treatment and to determine whether a treatment is effective or not. The biomarkers may also be used to select novel treatments and to screen for new potential compounds that may treat the triple negative breast cancer.
    Type: Application
    Filed: March 18, 2013
    Publication date: March 19, 2015
    Inventors: Azru Umar, Johannes Albert Foekens
  • IDENTIFYING CIRCULATING TUMOR CELLS (CTCS) USING CD146 IN BREAST CANCER PATIENTS
    Publication number: 20120178645
    Abstract: The present invention relates to a method for diagnosing cancer in a subject said method comprising the steps of providing a biological sample from a subject, and determining the expression of the MCAM gene in a circulating tumor cell (CTC) in said biological sample.
    Type: Application
    Filed: June 26, 2009
    Publication date: July 12, 2012
    Inventors: Johannes Albert Foekens, Johannes Wihelmus Maria Martens, Jaco Kraan, Stefan Sleijfer, Bianca Mostert, Anita Maria Sieuwerts
  • METHOD FOR DETERMINING THE ESTROGEN RECEPTOR STATUS OF BREAST CANCER
    Publication number: 20120046199
    Abstract: The present invention relates to a method for determining the estrogen receptor status of patients suffering from breast cancer. The present invention also aims to provide methods and devices for predicting the response of patients diagnosed with breast cancer to specific medicaments. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels and profiles in samples obtained from patients diagnosed with breast cancer.
    Type: Application
    Filed: April 12, 2010
    Publication date: February 23, 2012
    Applicant: PAMGENE B.V.
    Inventors: Robby Ruijtenbeek, Maria Helena Hilhorst, Arzu Umar, Johannes Albert Foekens, Johannes Wilhelmus Maria Martens